Related Experiment Video
Updated: Apr 25, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Perturbation of NCOA6 leads to dilated cardiomyopathy
Jae-Il Roh1, Cheolho Cheong2, Young Hoon Sung1
1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, South Korea; Yonsei Laboratory Animal Research Center, Yonsei University, Seoul 120-749, South Korea.
Abstract:
Dilated cardiomyopathy (DCM) is a progressive heart disease characterized by left ventricular dilation and contractile dysfunction. Although many candidate genes have been identified with mouse models, few of them have been shown to be associated with DCM in humans. Germline depletion of Ncoa6, a nuclear hormone receptor coactivator, leads to embryonic lethality and heart defects. However, it is unclear whether Ncoa6 mutations cause heart diseases in adults. Here, we report that two independent mouse models of NCOA6 dysfunction develop severe DCM with impaired mitochondrial function and reduced activity of peroxisome proliferator-activated receptor δ (PPARδ), an NCOA6 target critical for normal heart function. Sequencing of NCOA6-coding regions revealed three independent nonsynonymous mutations present in 5 of 50 (10%) patients with idiopathic DCM (iDCM). These data suggest that malfunction of NCOA6 can cause DCM in humans.
Insights
Mutations in the NCOA6 gene are linked to dilated cardiomyopathy (DCM), a serious heart condition. This discovery offers new insights into the genetic causes of DCM in adults.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Human Disease Genetics
Background:
- Dilated cardiomyopathy (DCM) is a progressive heart condition marked by left ventricular enlargement and impaired contractility.
- While mouse models have identified candidate genes, their direct link to human DCM remains limited.
- Nuclear hormone receptor coactivator 6 (NCOA6) deficiency causes embryonic lethality and heart defects, but its role in adult heart disease is unknown.
Purpose of the Study:
- To investigate the role of NCOA6 dysfunction in adult dilated cardiomyopathy.
- To determine if mutations in NCOA6 are associated with idiopathic DCM (iDCM) in human patients.
Main Methods:
- Generated and analyzed two independent mouse models with NCOA6 dysfunction.
- Assessed cardiac function, mitochondrial function, and peroxisome proliferator-activated receptor delta (PPARδ) activity in mouse models.
- Sequenced NCOA6-coding regions in patients diagnosed with idiopathic DCM.
Main Results:
- Mouse models of NCOA6 dysfunction exhibited severe DCM, impaired mitochondrial function, and reduced PPARδ activity.
- Three distinct nonsynonymous NCOA6 mutations were identified in 5 out of 50 (10%) iDCM patients.
- NCOA6 is a critical target for PPARδ, which is essential for normal heart function.
Conclusions:
- NCOA6 dysfunction can lead to severe dilated cardiomyopathy in mouse models.
- NCOA6 mutations are present in a subset of patients with idiopathic DCM, suggesting a causal link.
- NCOA6 plays a crucial role in maintaining adult heart function, potentially through its regulation of PPARδ.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management
Myocarditis I: Introduction

